Last updated on May 2018

Comparison of Aerosol Infasurf to Usual Care for Respiratory Distress Syndrome (RDS)

Brief description of study

For newborn infants born with a deficiency in lung surfactant because of prematurity or other causes of delayed lung maturation, lung surfactant replacement therapy is life saving. The objective of this trial is to demonstrate that there is a group of patients who can benefit from surfactant replacement therapy with lower risk of administration complications and less discomfort by utilizing an alternative, safer administration technique – aerosolization. 

Clinical Study Identifier: TX155612

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.